跳至主要内容
临床试验/NCT05964374
NCT05964374已完成不适用

Goal-Directed Therapy (GDT) Using Hypotension Prediction Index (HPI) Following Cardiac Surgery: a Pilot Randomized Control Trial

University of Calgary1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
24-hour cumulative IV fluid administration

研究概览

简要总结

Pilot prospective randomized control trial comparing goal-directed therapy algorithm vs routine care in the intensive care unit following cardiac surgery.

详细描述

Rationale:

Goal-directed therapy (GDT) has been shown to reduce complications and length of stay on cardiac surgery patients. Unfortunately, the existing literature on GDT in CV surgery has several limitations, which creates uncertainty over the expected benefit of implementing this care element with high associated costs and impact on workflow. Hypotension Prediction Index (HPI) is a proprietary algorithm that utilizes pulse contour analysis from invasive arterial pressure monitoring to identify patients at risk for becoming hypotensive within 15 minutes. The algorithm was developed using machine learning on a large surgical/ICU data set, and then externally validated on non-cardiac and cardiac surgical patients. HPI, as part of a GDT algorithm, may allow healthcare providers to identify patients recovering from cardiac surgery who may benefit from optimization prior to becoming hypotensive and assist with selecting the most appropriate hemodynamic intervention.

Hypothesis:

Application of an HPI-based GDT algorithm will result in a difference in cumulative fluid administration over the first 24-hours of index ICU admission following cardiac surgery.

Study Design:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years of age
  • Planned cardiac surgery using cardiopulmonary bypass (sternotomy or MICS)
  • Preoperative European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) of 2% or more.
  • Informed consent obtained.

排除标准

  • Emergency surgery
  • Patients who refuse participation
  • Patients who are unable to give informed consent
  • Patients who are having a heart or lung transplant.
  • Surgery for insertion of any ventricular assist device
  • Aortic arch procedures with any degree of debranching or hybrid with endovascular intervention in the ascending aorta +/- arch.
  • Patients who require MCS (including ECMO, Impella, or IABP) post-operatively
  • Patients on contact/droplet isolation.
  • Patients deemed excessively unstable and/or complex by their attending intensivist on arrival to the ICU.
  • If the post-operative arterial line MAP goal is not 65 mmHg.
  • Patients who suffer intra-operative mortality.

研究组 & 干预措施

Control

No Intervention

Routine post-operative clinical care.

Intervention

Experimental

Goal-directed therapy algorithm in addition to routine post-operative clinical care.

干预措施: Goal-directed therapy (Device)

结局指标

主要结局

24-hour cumulative IV fluid administration

时间窗: 24-hours

Cumulative post-operative intravenous fluid administration over the first 24-hours of index ICU admission.

次要结局

  • Study Protocol Compliance(1-year)
  • Arterial Monitoring Reliability(1-year)
  • Mobilization(Index admission, up to 30-days)
  • Hydration(Index admission, up to 30-days)
  • Mortality(Up to 1-year post-operative)
  • Nutrition(Index admission, up to 30-days)
  • Patient-centered Outcome(30-days)
  • Re-admission(30-days)
  • Mobilzation(Index admission, up to 30-days)
  • Length of Stay(Up to 1-year post-operative)
  • Fluid Administration(Duration of ICU stay, up to 30-days)
  • Vasoactive medication administration(Duration of ICU stay, up to 30-days)
  • Hemodynamic parameters(48-hours or when arterial line removed)
  • Enrollment(1-year)
  • GDT algorithm compliance(48-hours or when arterial line removed)
  • End-organ dysfunction/injury(Index admission, up to 30-days)
  • Transfusion(Index admission, up to 30-days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验